Kerala Ayurveda [KERALAYUR] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Kerala Ayurveda Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Kerala Ayurveda Ltd. wins in 5 metrics, Sun Pharmaceutical Industries Ltd. wins in 13 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Kerala Ayurveda Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 617.16 36.73 Sun Pharmaceutical Industries Ltd.
Price-to-Book Ratio 39.17 5.15 Sun Pharmaceutical Industries Ltd.
Debt-to-Equity Ratio 938.32 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio 11.48 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA -15.24 23.61 Sun Pharmaceutical Industries Ltd.
Profit Margin (TTM) -18.52% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) -8.08% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) N/A 26.17% N/A
Return on Equity 140.14% 15.08% Kerala Ayurveda Ltd.
Return on Assets (TTM) -10.84% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-84.95M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return -53.05% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 2.49 7.05 Kerala Ayurveda Ltd.
Enterprise Value $3.73B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 2.93 6.66 Kerala Ayurveda Ltd.
Gross Profit Margin (TTM) 87.04% 80.96% Kerala Ayurveda Ltd.
Revenue per Share (TTM) $105 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $-19.60 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.08 0.11 Kerala Ayurveda Ltd.

Kerala Ayurveda Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

KERALAYUR
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kerala Ayurveda Ltd.-2.98%-14.09%-15.84%-20.57%-50.84%-46.37%
Sun Pharmaceutical Industries Ltd.-0.47%-3.03%-1.92%2.17%-1.01%3.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kerala Ayurveda Ltd.-53.05%64.05%238.54%225.21%225.76%263.24%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Kerala Ayurveda Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricKERALAYURSUNPHARMA
Market Information
Market Cap i₹3.10B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i11,5833,903,142
90 Day Avg. Volume i41,9863,253,866
Last Close₹169.55₹1,780.10
52 Week Range₹150.00 - ₹625.00₹1,548.00 - ₹1,916.60
% from 52W High-72.87%-7.12%
All-Time High₹625.00 (Jul 01, 2025)₹1,960.35 (Sep 30, 2024)
% from All-Time High-72.87%-9.19%
Growth Metrics
Quarterly Revenue Growth0.06%0.14%
Quarterly Earnings Growth0.06%0.16%
Financial Health
Profit Margin (TTM) i-0.19%0.19%
Operating Margin (TTM) i-0.08%0.26%
Return on Equity (TTM) i1.40%0.15%
Debt to Equity (MRQ) i938.326.68
Cash & Liquidity
Book Value per Share (MRQ)₹6.23₹324.46
Cash per Share (MRQ)₹4.08₹115.87
Operating Cash Flow (TTM) i₹43.75M₹110.84B
Levered Free Cash Flow (TTM) i₹-139,590,000₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A₹16.50

Valuation & Enterprise Metrics Analysis: Kerala Ayurveda Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricKERALAYUR (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i617.1636.73
Forward P/E iN/A29.48
PEG Ratio i11.483.59
Price to Sales (TTM) i2.497.05
Price to Book (MRQ) i39.175.15
Market Capitalization
Market Capitalization i₹3.10B₹3.88T
Enterprise Value i₹3.73B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i2.936.66
Enterprise to EBITDA i-15.2423.61
Risk & Other Metrics
Beta i0.080.11
Book Value per Share (MRQ) i₹6.23₹324.46

Financial Statements Comparison: Kerala Ayurveda Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricKERALAYUR (2025)SUNPHARMA (2025)
Revenue/Sales i1.19B520.41B
Cost of Goods Sold i249.68M121.98B
COGS % of Revenue i21.0%23.4%
Gross Profit i942.01M398.44B
Gross Margin i79.0%76.6%
Research & Development i1.26MN/A
Operating Income (EBIT) i-99.66M125.81B
Operating Margin i-8.4%24.2%
EBITDA i-42.40M167.25B
EBITDA Margin i-3.6%32.1%
Pre-Tax Income i-122.36M137.52B
Pre-Tax Income % of Revenue i-10.3%26.4%
Income Tax i17.23M27.72B
Income Tax % of Revenue i1.4%5.3%
Net Income (Profit) i-139.59M109.65B
Profit Margin i-11.7%21.1%

Balance Sheet & Liquidity Metrics

MetricKERALAYUR (2025)SUNPHARMA (2025)
Cash & Equivalents i33.89M102.69B
Total Current Assets i407.67M526.24B
Total Current Assets % of Revenue i34.2%101.1%
Total Current Liabilities i879.75M181.94B
Total Current Liabilities % of Revenue i73.8%35.0%
Long-Term Debt i222.20M3.58B
Long-Term Debt % of Revenue i18.6%0.7%
Total Shareholders Equity i-99.60M724.86B
Retained Earnings iN/A578.62B
Retained Earnings % of Revenue i0.0%111.2%
Property, Plant & Equipment i10.08M100.36B

Cash Flow Statement Comparison

MetricKERALAYUR (2025)SUNPHARMA (2025)
Operating Cash Flow i43.75M110.84B
Operating Cash Flow % of Revenue i3.7%21.3%
Capital Expenditures i-133.20M-20.68B
Free Cash Flow i-84.95M119.44B
FCF Margin i-7.1%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricKERALAYURSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i13.00M2.40B
Float Shares i6.30M1.07B
% Held by Insiders i52.41%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i47.59%15.69%

Dividend Analysis & Yield Comparison: Kerala Ayurveda Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricKERALAYURSUNPHARMA
Last 12-Month Dividend iN/A₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends iN/A₹52.00
Ex-Dividend DateN/AFeb 05, 2026